in

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

For patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does reduce some cardiovascular events, according to a study published online Nov. 27 in eClinicalMedicine.


Posted by Editor

Netanyahu says Gaza-Egypt border zone should be under Israeli control

Netanyahu says Gaza-Egypt border zone should be under Israeli control

horoscope

Daily horoscope: December 31, 2023 astrological predictions for your star sign